| Lastest Insider Transactions Of Mereo BioPharma Group plc ( MREO ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| MREO | Mereo BioPharma Group plc | Scots-Knight Denise | Chief Executive Officer | 2024-09-12 | Sell | 88,657 | 4.30 | 381,423 | 2024-09-16 20:50:10 |
| MREO | Mereo BioPharma Group plc | Lewicki John A. | Chief Scientific Officer | 2024-09-12 | Sell | 16,149 | 4.30 | 69,477 | 2024-09-16 20:49:03 |
| MREO | Mereo BioPharma Group plc | Sermon Charles | General Counsel | 2024-09-12 | Sell | 30,926 | 4.30 | 133,051 | 2024-09-16 20:48:57 |
| MREO | Mereo BioPharma Group plc | Fox Christine Ann | Chief Financial Officer | 2024-09-12 | Sell | 28,286 | 4.30 | 121,693 | 2024-09-16 20:47:45 |
| MREO | Mereo BioPharma Group plc | Hughes-Wilson Alexandra | See Remarks | 2024-09-12 | Sell | 148,110 | 4.30 | 637,203 | 2024-09-16 20:46:34 |
| MREO | Mereo BioPharma Group plc | Sermon Charles | General Counsel | 2024-09-11 | Option Exercise | 65,600 | 0.00 | 0 | 2024-09-13 16:57:13 |
| MREO | Mereo BioPharma Group plc | Fox Christine Ann | Chief Financial Officer | 2024-09-11 | Option Exercise | 60,000 | 0.00 | 0 | 2024-09-13 16:50:17 |
| MREO | Mereo BioPharma Group plc | Lewicki John A. | Chief Scientific Officer | 2024-09-11 | Option Exercise | 46,000 | 0.00 | 0 | 2024-09-13 16:49:18 |
| MREO | Mereo BioPharma Group plc | Scots-Knight Denise | Chief Executive Officer | 2024-09-11 | Option Exercise | 188,060 | 0.00 | 0 | 2024-09-13 16:49:08 |
| MREO | Mereo BioPharma Group plc | Hughes-Wilson Alexandra | See Remarks | 2024-09-11 | Option Exercise | 208,333 | 0.99 | 206,416 | 2024-09-13 16:47:50 |
| MREO | Mereo BioPharma Group plc | Sermon Charles | General Counsel | 2024-06-25 | Sell | 46,389 | 3.49 | 161,678 | 2024-06-27 16:15:47 |
| MREO | Mereo BioPharma Group plc | Lewicki John A. | Chief Scientific Officer | 2024-06-25 | Sell | 24,224 | 3.49 | 84,427 | 2024-06-27 16:15:33 |
| MREO | Mereo BioPharma Group plc | Fox Christine Ann | Chief Financial Officer | 2024-06-25 | Sell | 42,429 | 3.49 | 147,876 | 2024-06-27 16:15:31 |
| MREO | Mereo BioPharma Group plc | Scots-Knight Denise | Chief Executive Officer | 2024-06-25 | Sell | 132,985 | 3.49 | 463,487 | 2024-06-27 16:15:26 |
| MREO | Mereo BioPharma Group plc | Hughes-Wilson Alexandra | See Remarks | 2024-06-25 | Sell | 33,102 | 3.49 | 115,369 | 2024-06-27 16:15:03 |
| MREO | Mereo BioPharma Group plc | Lewicki John A. | Chief Scientific Officer | 2024-06-21 | Option Exercise | 69,000 | 0.00 | 0 | 2024-06-25 18:21:23 |
| MREO | Mereo BioPharma Group plc | Scots-Knight Denise | Chief Executive Officer | 2024-06-21 | Option Exercise | 282,090 | 0.00 | 0 | 2024-06-25 18:15:01 |
| MREO | Mereo BioPharma Group plc | Sermon Charles | General Counsel | 2024-06-21 | Option Exercise | 98,400 | 0.00 | 0 | 2024-06-25 18:14:31 |
| MREO | Mereo BioPharma Group plc | Fox Christine Ann | Chief Financial Officer | 2024-06-21 | Option Exercise | 90,000 | 0.00 | 0 | 2024-06-25 18:13:45 |
| MREO | Mereo BioPharma Group plc | Hughes-Wilson Alexandra | See Remarks | 2024-06-21 | Option Exercise | 60,000 | 0.00 | 0 | 2024-06-25 18:13:43 |
| MREO | Mereo BioPharma Group plc | Hughes-Wilson Alexandra | See Remarks | 2024-05-22 | Sell | 100,432 | 2.97 | 297,788 | 2024-05-23 21:54:37 |
| MREO | Mereo BioPharma Group plc | Hughes-Wilson Alexandra | See Remarks | 2024-05-22 | Option Exercise | 168,333 | 1.23 | 206,416 | 2024-05-23 21:54:37 |
